| 1053P Tumor-restricted delivery of an immune-therapeutic payload by modified macrophages for the treatment of glioblastoma: The TEM-GBM STUDY (NCT03866109) F Ciceri, B Gentner, A Capotondo, M Eoli, E Anghileri, F Farina, ... Annals of Oncology 34, S637, 2023 | | 2023 |
| 1H NMR detects different metabolic profiles in glioblastoma stem‐like cells L Guidoni, L Ricci‐Vitiani, A Rosi, A Palma, S Grande, AM Luciani, ... NMR in Biomedicine 27 (2), 129-145, 2014 | 29 | 2014 |
| 1H NMR spectroscopy of glioblastoma stem‐like cells identifies alpha‐aminoadipate as a marker of tumor aggressiveness A Rosi, L Ricci‐Vitiani, M Biffoni, S Grande, AM Luciani, A Palma, D Runci, ... NMR in Biomedicine 28 (3), 317-326, 2015 | 26 | 2015 |
| 2005 SRC PUBLICATIONS BR Richter, B Gilbert, S Schaub, RJ Cannara, JF Crawford, MK Gilles, ... Journal of Physics B-Atomic Molecular and Optical Physics 38 (16), L269-L275, 2005 | | 2005 |
| 214 Human ependymoma tumor-initiating cells (TICs) as a model for preclinical studies on EGFR-kinase inhibitors (EGFR-KIs) D Meco, T Servidei, N Trivieri, GF Zannoni, R Pallini, G Maira, R Riccardi Ejc Supplements 7 (8), 70-71, 2010 | | 2010 |
| 284MO Targeting the tumor microenvironment of glioblastoma multiforme using a macrophage-based treatment for the local delivery of immune-therapeutic payload: The TEM-GBM study … G Finocchiaro, M Eoli, F Farina, B Gentner, A Capotondo, E Anghileri, ... Annals of Oncology 33, S669, 2022 | 1 | 2022 |
| 307. Metabolic heterogeneity among Glioblastoma stem-like cells reflects differences in response to drug treatments A Palma, S Grande, L Ricci-Vitiani, AM Luciani, M Buccarelli, M Biffoni, ... Physica Medica: European Journal of Medical Physics 56, 250-251, 2018 | | 2018 |
| 379TiP TEM-GBM: A phase I-IIa clinical study of genetically modified Tie-2-expressing monocytes in patients with glioblastoma multiforme G Finocchiaro, B Gentner, M Eoli, A Capotondo, F Farina, E Anghileri, ... Annals of Oncology 32, S528, 2021 | | 2021 |
| 5-Aminolevulinic Acid (5-ALA)-induced protoporphyrin IX fluorescence by glioma cells—a fluorescence microscopy clinical study S Pacioni, QG D’Alessandris, S Giannetti, GM Della Pepa, M Offi, ... Cancers 14 (12), 2844, 2022 | 10 | 2022 |
| 5-Aminolevulinic Acid (5-ALA)–Induced Protoporphyrin IX Fluorescence by Glioma Cells—A Fluorescence Microscopy Clinical Study. Cancers 2022, 14, 2844 S Pacioni, QG D’Alessandris, S Giannetti, GM Della Pepa, M Offi, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 2 | 2022 |
| 639 Intra-tumor delivery of IFN-alpha by Tie-2 transduced monocytes associated with favorable 2-year survival in unmethylated MGMT GBM patients: preliminary results of TEM-GBM … C Russo, B Gentner, M Eoli, F Farina, E Anghileri, M Barcella, V Brambilla, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 648 Autologous macrophage-based immunotherapy Induces a pro-inflammatory state in GBM tumor microenvironment–(TEM-GBM) G Finocchiaro, B Gentner, M Eoli, F Farina, A Capotondo, E Anghileri, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells CM Tate, R Pallini, L Ricci-Vitiani, M Dowless, T Shiyanova, ... Cell Death & Differentiation 19 (10), 1644-1654, 2012 | 73 | 2012 |
| A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology CM Tate, J Mc Entire, R Pallini, E Vakana, L Wyss, W Blosser, ... PLoS One 10 (4), e0125697, 2015 | 16 | 2015 |
| A case of high jugular bulb F Salvinelli, M Trivelli, F Greco, R Pallini RIVISTA ITALIANA DI PEDIATRIA 27 (2), 275-278, 2001 | | 2001 |
| A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells CL Esposito, S Nuzzo, SA Kumar, A Rienzo, CL Lawrence, R Pallini, ... Journal of Controlled Release 238, 43-57, 2016 | 86 | 2016 |
| A phase I-IIa study of genetically modified Tie-2 expressing monocytes in patients with glioblastoma multiforme (TEM-GBM Study). G Finocchiaro, B Gentner, F Farina, A Capotondo, M Eoli, E Anghileri, ... Journal of Clinical Oncology 39 (15_suppl), 2532-2532, 2021 | 12 | 2021 |
| A risk score based on 5 clinico-pathological variables predicts recurrence of atypical meningiomas A Fioravanzo, M Caffo, R Di Bonaventura, MP Gardiman, C Ghimenton, ... Journal of Neuropathology & Experimental Neurology 79 (5), 500-507, 2020 | 19 | 2020 |
| A Three-Dimensional Organoid Culture System to Model Invasive Patterns of Patient-Derived Glioma Stem Cells A Mariappan, T Knauth, R Pallini, J Gopalakrishnan Brain Organoid Research, 139-158, 2022 | | 2022 |
| A three‐microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes G Marziali, M Buccarelli, A Giuliani, R Ilari, S Grande, A Palma, ... Molecular oncology 11 (9), 1115-1129, 2017 | 36 | 2017 |
